Re: Conflict-of-interest in medicine continues..
Posted by Sharon on 10/04/08
Just an answer: Yes, I believe that is correct. And McCain
wants to deregulate health care...just like the finance
industry has been deregulated?
Surely, the folly of that HAS to be recognized somewhere, just
like Buffett saw this whole financial melt down coming from
unregulated and uchecked greed.
had to add spaces to get past the filter
s e e k i n g a l p h a . c o m / a r t i c l e / 3 4 6 0 6 -b
u f f e t t - o n - d e r i v a t i v e s - a - f o o l - s -g
a m e
On 10/04/08, Myco X wrote:
> Wait -- Emory University?
>
> Isn't that located in Atlanta?
>
> Where the CDC is headquartered?
>
> Doesn't the CDC outsource consultation to Emory staff on the
subject of mold
> and human health?
>
> Just a question...
>
> Myco
>
>
> On 10/04/08, Deborah wrote:
>>
>>
>> Unlikely any different in any other discipline..
>>
>> October 4, 2008
>> Top Psychiatrist Didn’t Report Drug Makers’ Pay
>> By GARDINER HARRIS
>> One of the nation’s most influential psychiatrists earned
>> more than $2.8 million in consulting arrangements with
>> drug makers from 2000 to 2007, failed to report at least
>> $1.2 million of that income to his university and violated
>> federal research rules, according to documents provided to
>> Congressional investigators.
>>
>> The psychiatrist, Dr. Charles B. Nemeroff of Emory
>> University, is the most prominent figure to date in a
>> series of disclosures that is shaking the world of
>> academic medicine and seems likely to force broad changes
>> in the relationships between doctors and drug makers.
>>
>> In one telling example, Dr. Nemeroff signed a letter dated
>> July 15, 2004, promising Emory administrators that he
>> would earn less than $10,000 a year from GlaxoSmithKline
>> to comply with federal rules. But on that day, he was at
>> the Four Seasons Resort in Jackson Hole, Wyo., earning
>> $3,000 of what would become $170,000 in income that year
>> from that company — 17 times the figure he had agreed on.
>>
>> The Congressional inquiry, led by Senator Charles E.
>> Grassley, Republican of Iowa, is systematically asking
>> some of the nation’s leading researchers to provide their
>> conflict-of-interest disclosures, and Mr. Grassley is
>> comparing those documents with records of actual payments
>> from drug companies. The records often conflict, sometimes
>> starkly.
>>
>> “After questioning about 20 doctors and research
>> institutions, it looks like problems with transparency are
>> everywhere,” Mr. Grassley said. “The current system for
>> tracking financial relationships isn’t working.”
>>
>>
>> http://www.nytimes.com/2008/10/04/health/policy/04drug.html
>> ?em
>
| You are on the BLACKMOLD CHATBOARD: LATEST POSTS ALL POSTS SUBMIT POST |
| ||||||||||
|